Brief: Adma Biologics Announces Second Quarter 2022 Financial Results And Provides Business Update
Aug 10 (Reuters) - ADMA Biologics Inc ADMA.O :
* ADMA BIOLOGICS ANNOUNCES SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q2 REVENUE ROSE 90 PERCENT TO $33.9 MILLION
* FULL YEAR 2022 TOTAL REVENUES EXPECTED TO EXCEED $130
MILLION
* CONTINUES TO ANTICIPATE GENERATING APPROXIMATELY $250
MILLION OR
MORE IN TOPLINE REVENUE IN 2024
* QTRLY LOSS PER SHARE $0.07
Source text for Eikon: ID:nGNX1NvMKf
Further company coverage: ADMA.O
((Reuters.Briefs@thomsonreuters.com;))